FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3085188429> ?p ?o ?g. }

• W3085188429 endingPage "2236" @default.
• W3085188429 startingPage "2229" @default.
• W3085188429 abstract "High-dose melphalan (Mel) conditioning before autologous hematopoietic cell transplantation (autoHCT) is standard of care for patients with transplantation-eligible multiple myeloma. The traditional lyophilized Mel formulation has inadequate solubility and stability after reconstitution, leading to the use of propylene glycol (PG) as a solubilizing agent. A newer PG-free Mel preparation (Evomela) uses beta cyclodextrin captisol as a solubilizing agent and was approved by the United States Food and Drug Administration as a conditioning agent based on a single-phase IIb study showing bioequivalence. We compared the outcomes of consecutive patients with myeloma undergoing autoHCT using the 2 formulations of Mel for conditioning as our center switched from using the older formulation (PG-Mel) to the newer one (PGF-Mel). Of 294 autoHCT recipients, 162 received PG-Mel conditioning and 132 received PGF-Mel conditioning. The PGF-Mel group was older and had a lower average Karnofsky Performance Status score. PGF-Mel was associated with faster neutrophil recovery (median, 12 days versus 13 days; P < .001), fewer grade 3-4 infections within 30 days of autoHCT (1.5% versus 8.0%; P = .048), and a lower 30-day rehospitalization rate (6.8% versus 17.9%; P = .04), as confirmed by propensity-weighted analysis. No significant between-group differences were detected in mucositis, organ toxicity, myeloma response, or 100-day mortality." @default.
• W3085188429 created "2020-09-21" @default.
• W3085188429 creator A5011030256 @default.
• W3085188429 creator A5022627454 @default.
• W3085188429 creator A5028564534 @default.
• W3085188429 creator A5030770484 @default.
• W3085188429 creator A5031690184 @default.
• W3085188429 creator A5036605555 @default.
• W3085188429 creator A5039679523 @default.
• W3085188429 creator A5058783159 @default.
• W3085188429 creator A5086815330 @default.
• W3085188429 creator A5090009002 @default.
• W3085188429 creator A5090375120 @default.
• W3085188429 date "2020-12-01" @default.
• W3085188429 modified "2023-09-23" @default.
• W3085188429 title "Propylene Glycol-Free Melphalan versus PG-Melphalan as Conditioning for Autologous Hematopoietic Cell Transplantation for Myeloma" @default.
• W3085188429 cites W1598232851 @default.
• W3085188429 cites W1614863993 @default.
• W3085188429 cites W1931964440 @default.
• W3085188429 cites W1985343070 @default.
• W3085188429 cites W1985482871 @default.
• W3085188429 cites W1992433800 @default.
• W3085188429 cites W2039793136 @default.
• W3085188429 cites W2044225326 @default.
• W3085188429 cites W2074157250 @default.
• W3085188429 cites W2075666986 @default.
• W3085188429 cites W2120474651 @default.
• W3085188429 cites W2127143739 @default.
• W3085188429 cites W2128812336 @default.
• W3085188429 cites W2143425592 @default.
• W3085188429 cites W2172469237 @default.
• W3085188429 cites W2299494654 @default.
• W3085188429 cites W2321053053 @default.
• W3085188429 cites W2486629951 @default.
• W3085188429 cites W2565519595 @default.
• W3085188429 cites W2604776612 @default.
• W3085188429 cites W2606797830 @default.
• W3085188429 cites W2782083840 @default.
• W3085188429 cites W2801994202 @default.
• W3085188429 cites W2802003818 @default.
• W3085188429 cites W2887812219 @default.
• W3085188429 cites W2896565415 @default.
• W3085188429 cites W3099724350 @default.
• W3085188429 cites W3145716452 @default.
• W3085188429 doi "https://doi.org/10.1016/j.bbmt.2020.08.030" @default.
• W3085188429 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32920204" @default.
• W3085188429 hasPublicationYear "2020" @default.
• W3085188429 type Work @default.
• W3085188429 sameAs 3085188429 @default.
• W3085188429 citedByCount "5" @default.
• W3085188429 countsByYear W30851884292022 @default.
• W3085188429 countsByYear W30851884292023 @default.
• W3085188429 crossrefType "journal-article" @default.
• W3085188429 hasAuthorship W3085188429A5011030256 @default.
• W3085188429 hasAuthorship W3085188429A5022627454 @default.
• W3085188429 hasAuthorship W3085188429A5028564534 @default.
• W3085188429 hasAuthorship W3085188429A5030770484 @default.
• W3085188429 hasAuthorship W3085188429A5031690184 @default.
• W3085188429 hasAuthorship W3085188429A5036605555 @default.
• W3085188429 hasAuthorship W3085188429A5039679523 @default.
• W3085188429 hasAuthorship W3085188429A5058783159 @default.
• W3085188429 hasAuthorship W3085188429A5086815330 @default.
• W3085188429 hasAuthorship W3085188429A5090009002 @default.
• W3085188429 hasAuthorship W3085188429A5090375120 @default.
• W3085188429 hasBestOaLocation W30851884291 @default.
• W3085188429 hasConcept C105795698 @default.
• W3085188429 hasConcept C109159458 @default.
• W3085188429 hasConcept C126322002 @default.
• W3085188429 hasConcept C126894567 @default.
• W3085188429 hasConcept C141071460 @default.
• W3085188429 hasConcept C143998085 @default.
• W3085188429 hasConcept C2776364478 @default.
• W3085188429 hasConcept C2776694085 @default.
• W3085188429 hasConcept C2777408962 @default.
• W3085188429 hasConcept C2778496288 @default.
• W3085188429 hasConcept C2778684742 @default.
• W3085188429 hasConcept C28328180 @default.
• W3085188429 hasConcept C2911091166 @default.
• W3085188429 hasConcept C2993713153 @default.
• W3085188429 hasConcept C33923547 @default.
• W3085188429 hasConcept C45262634 @default.
• W3085188429 hasConcept C54355233 @default.
• W3085188429 hasConcept C71924100 @default.
• W3085188429 hasConcept C86803240 @default.
• W3085188429 hasConceptScore W3085188429C105795698 @default.
• W3085188429 hasConceptScore W3085188429C109159458 @default.
• W3085188429 hasConceptScore W3085188429C126322002 @default.
• W3085188429 hasConceptScore W3085188429C126894567 @default.
• W3085188429 hasConceptScore W3085188429C141071460 @default.
• W3085188429 hasConceptScore W3085188429C143998085 @default.
• W3085188429 hasConceptScore W3085188429C2776364478 @default.
• W3085188429 hasConceptScore W3085188429C2776694085 @default.
• W3085188429 hasConceptScore W3085188429C2777408962 @default.
• W3085188429 hasConceptScore W3085188429C2778496288 @default.
• W3085188429 hasConceptScore W3085188429C2778684742 @default.
• W3085188429 hasConceptScore W3085188429C28328180 @default.
• W3085188429 hasConceptScore W3085188429C2911091166 @default.
• W3085188429 hasConceptScore W3085188429C2993713153 @default.

• next